PLGA Implants for Controlled Drug Release
A special issue of Pharmaceutics (ISSN 1999-4923). This special issue belongs to the section "Drug Delivery and Controlled Release".
Deadline for manuscript submissions: 10 December 2025 | Viewed by 174
Special Issue Editor
Interests: nanoparticles; drug delivery; liposomes; lipid nanoparticles; PLGA nanoparticles; PLA nanoparticles
Special Issue Information
Dear Colleagues,
The following Special Issue (SI), entitled "PLGA Implants for Controlled Drug Release", explores recent advances in the field of drug implants. The SI highlights the increasing demand for long-acting, targeted therapies for various medical conditions. The scope includes innovative fabrication techniques such as 3D printing and predictive mathematical modeling to enhance the accuracy of release kinetics and degradation profiles. In addition, it covers patient-specific customization, combination, e.g., multiple drug molecules and nanoparticles, and strategies to address burst release.
With this collection, we aim to showcase cutting-edge research and advancements in design and fabrication while simultaneously exploring complex release mechanisms to enhance the clinical utility of these implants. We aim to provide a platform for scientists and researchers to share their findings, exchange ideas, and foster collaborations. This collection builds on existing knowledge, addresses current gaps in research, and offers a comprehensive overview of the latest developments and challenges in the field while additionally identifying directions for future research.
Dr. Emma Portnoy
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceutics is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- nanoparticles
- drug delivery
- liposomes
- lipid nanoparticles
- PLGA nanoparticles
- PLA nanoparticles
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
